Evaluation of reference intervals for biomarkers sensitive to alcohol consumption, excess body weight and oxidative stress

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 2, 2010, Pages 104-111

  Alatalo, Pivikki ^a,b   Koivisto, Heidi ^a,b   Kultti, Johanna ^a,b   Bloigu, Risto ^c   Niemel, Onni ^a,b  

^a Seinjoki Central Hospital   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Body mass index; Ethanol; Gamma glutamyltransferase; Normal limit; Overweight; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; DRINKING BEHAVIOR; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; LABORATORY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGING; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CREATINE KINASE; FEMALE; FINLAND; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; OXIDATIVE STRESS; REFERENCE VALUES; RISK; SEX CHARACTERISTICS; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 77949785268     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903548818     Document Type: Article

References (42)

1. Europe in figures - Eurostat yearbook 2008. Luxembourg: Office for Official Publications of the European Communities 2008 (ISBN 978-92-79-06607-8).
2. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006;367:52-56
3. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-1065
4. Ramstedt M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction 2001;96(Suppl. 1):S19-S33.
5. Rustad P. Nordic Reference Interval Project. http://www. furst.no/norip/.
6. Lahti A. Are the common reference intervals truly common? Case studies on stratifying biochemical reference data by countries using two partitioning methods. Scand J Clin Lab Invest 2004;64:407-430
7. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft PP, Simonsson P, Steensland H, Uldall A. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271-284
8. Felding P, Rustad P, Martensson A, Kairisto V, Franzson L, Hyltoft PP, Uldall A. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:327-342
9. Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987;25:645-656
10. Rustad P, Felding P, Lahti A, Hyltoft PP. Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:343-370
11. Sillanaukee P, Kiianmaa K, Roine R, Seppa K. Alkoholin suurkulutuksen kriteerit [Criteria of heavy drinking]. Suom Laakaril 1992;31:2919-2921
12. Mukamal KJ, Rimm EB. Alcohol consumption: risks and benefits. Curr Atheroscler Rep 2008;10:536-543
13. Tolstrup JS, Gronbaek M, Tybjaerg-Hansen A, Nordestgaard BG. Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population. Am J Gastroenterol 2009;104:2182-2188
14. Pratt DS, Kaplan MM. Evaluation of abnormal liverenzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-1271
15. Hietala J, Koivisto H, Anttila P, Niemela O. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006;41:528-533
16. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219
17. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander- Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474
18. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419
19. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005;42:650-656
20. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-1292
21. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960-967
22. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002;50:585-588
23. McNair A. Non-alcoholic steatohepatitis (NASH): why biopsy? Gut 2002;51:898-899
24. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008;47:1363-1370
25. Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Francesconi P, Buiatti E, Rotella CM, Mannucci E. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008;57:387-392
26. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-2137
27. Goessling W, Massaro JM, Vasan RS, D'Agostino RB, Sr., Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008;135:1935-1944
28. Ioannou GN. Implications of elevated serum alanine aminotransferase levels: think outside the liver. Gastroenterology 2008;135:1851-1854
29. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998;114:842-845
30. Carmiel-Haggai M, Cederbaum AI, Nieto N. Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 2003;125:1818-1833
31. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712
32. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44: 275-295
33. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2004;44:27-42.
34. Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu RS, Niemela OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008;88:1097-1103
35. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
36. Alatalo PI, Koivisto HM, Hietala JP, Bloigu RS, Niemela OJ. Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid - an index of oxidant stress status? Free Radic Biol Med 2009;46:1233-1238
37. Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007;17:409-414
38. Li JM, Mukamal KJ. An update on alcohol and atherosclerosis. Curr Opin Lipidol 2004;15:673-680
39. Sesso HD. Alcohol and cardiovascular health: recent findings. Am J Cardiovasc Drugs 2001;1:167-172
40. Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009;49:802-808
41. Stromme JH, Rustad P, Steensland H, Theodorsen L, Urdal P. Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest 2004;64:371-384
42. Rustad P, Hyltoft PP. Effect of analytical quality on establishing common reference intervals and their use. Scand J Clin Lab Invest 2004;64:399-406.